Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma

Figure 3

Construction of a pyroptosis-related prognostic signature. (a, b) The coefficient and partial likelihood deviance of prognostic signature. (c) The risk score distribution, survival status of LUSC cases and gene expression profile of this prognostic signature. (d, e) Overall survival curve in the high-/low-risk group and the ROC curve evaluating prognosis predicting performance of LUSC patients.

(a)

(b)

(c)

(d)

(e)